# \[e-drug\] Benzodiazepines use: consistent with recommendations?

**URL:** <https://talk.edrugplus.org/t/e-drug-benzodiazepines-use-consistent-with-recommendations/21535>\
**Category:** e-drug\
**Created:** [January 31, 2005, 11:31pm UTC](https://talk.edrugplus.org/t/e-drug-benzodiazepines-use-consistent-with-recommendations/21535 "2005-01-31T23:31:58Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Ciprian\_D\_Jauca](https://avatars.discourse-cdn.com/v4/letter/c/a9adbd/32.png) [@Ciprian\_D\_Jauca](https://talk.edrugplus.org/u/Ciprian_D_Jauca)\
**Post date:** [January 31, 2005, 11:31pm UTC](https://talk.edrugplus.org/t/e-drug-benzodiazepines-use-consistent-with-recommendations/21535/1 "2005-01-31T23:31:58Z")

</div>

E-DRUG: Benzodiazepines use: consistent with recommendations?  
---------------------------------------------------------------  
[BC = British Columbia, a anadian province/region WB]

Dear E-druggers,

I would like to bring to your attention the November/December 2004 issue  
(#54) of the Therapeutics Letter: "Use of Benzodiazepines in BC: Is it  
consistent with recommendations?" that has just been published on the  
Therapeutics Initiative web-site at [http://www.ti.ubc.ca/pages/letter54.htm](http://www.ti.ubc.ca/pages/letter54.htm)

In this Letter we describe the utilization of benzodiazepines in BC from  
1996 to 2002, and we see a pattern which appears inconsistent with the  
recommendations of educational groups, regulators and manufacturers.

I invite you to drop by and have a look at this Letter. Please feel free to  
forward this message to any of your friends or colleagues that might be  
interested in this topic.

We would appreciate receiving your comments on this Therapeutics Letter and  
its possible implications in clinical practice.

Best regards,  
Ciprian Jauca  
Manager  
Therapeutics Initiative  
University of British Columbia

Department of Pharmacology & Therapeutics  
2176 Health Sciences Mall  
Vancouver, BC V6T 1Z3  
Canada

Email: jauca@ti.ubc.ca  
Tel: +1 (604) 822-0700  
Fax: +1 (604) 822-0701  
Web: www.ti.ubc.ca
